Bone Biologics Corp (BBLG): Nasdaq/NYSE listing notice — Bone Biologics receives Nasdaq delisting notice for bid price non-compliance

Bone Biologics Corp

Received Nasdaq notice on Nov 17, 2022: common stock closing bid below $1.00 for 30 consecutive business days.
Compliance period of 180 calendar days until May 16, 2023 to regain minimum $1.00 bid price.
May qualify for second 180-day period if meeting other listing standards and notifying Nasdaq of intent to cure.
Company plans to assess potential actions but may be unable to regain compliance and face delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Bone Biologics Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

November 17, 2022, Bone Biologics Corporation (the “Company”) received a written notice (the “Notice”) from the NASDAQ Stock Market LLC (“Nasdaq”) that the Company has not been in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for a period of 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum closing bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum closing bid price requirement exists if the deficiency continues for a period of

View on SEC.gov

Browse all listing & compliance notices →

Bone Biologics Corp filing history →

Source: SEC EDGAR

accession 0001493152-22-033115

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.